• 1
    Pearce, E. J. and MacDonald, A. S., The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2002. 2: 499511.
  • 2
    Gause, W. C., Urban, J. F. and Stadecker, M. J., The immune response to parasitic helminths: insights from murine models. Trends Immunol. 2003. 24: 269277.
  • 3
    Cheever, A., Duvall, R., Hallack, T., Jr., Minker, R., Malley, J. and Malley, K., Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1987. 37: 8597.
  • 4
    Fanning, M., Peters, P., Davis, R., Kazura, J. and Mahmoud, A., Immunopathology of murine infection with Schistosoma mansoni: relationship of genetic background to hepatosplenic disease and modulation. J. Infect. Dis. 1981. 144: 148153.
  • 5
    Phillips, S. M., DiConza, J. J., Gold, J. A. and Reid, W. A., Schistosomiasis in the congenitally athymic (nude) mouse. I. Thymic dependency of eosinophilia, granuloma formation, and host morbidity. J. Immunol. 1977. 118: 594599.
  • 6
    Hernandez, H. J., Wang, Y., Tzellas, N. and Stadecker, M. J., Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur. J. Immunol. 1997. 27: 11701176.
  • 7
    Iacomini, J., Ricklan, D. and Stadecker, M., T cells expressing the γδ T cell receptor are not required for egg granuloma formation in schistosomiasis. Eur. J. Immunol. 1995. 25: 884888.
  • 8
    Stadecker, M. J., Asahi, H., Finger, E., Hernandez, H. J., Rutitzky, L. I. and Sun, J., The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol. Rev. 2004. 201: 168179.
  • 9
    Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W. and Wynn, T. A., An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 1999. 104: 777785.
  • 10
    Fallon, P. G., Richardson, E. J., McKenzie, G. J. and McKenzie, A. N., Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 2000. 164: 25852591.
  • 11
    Rutitzky, L. I., Hernandez, H. J. and Stadecker, M. J., Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc. Natl. Acad. Sci. USA 2001. 98: 1324313248.
  • 12
    Rutitzky, L. I., Lopes da Rosa, J. R. and Stadecker, M. J., Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 2005. 175: 39203926.
  • 13
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 14
    Chu, C. Q., Swart, D., Alcorn, D., Tocker, J. and Elkon, K. B., Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 2007. 56: 11451151.
  • 15
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 16
    Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003. 278: 19101914.
  • 17
    Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235238.
  • 18
    Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 16851691.
  • 19
    Iwakura, Y., Nakae, S., Saijo, S. and Ishigame, H., The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 2008. 226: 5779.
  • 20
    Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179189.
  • 21
    Rutitzky, L. I., Bazzone, L., Shainheit, M. G., Joyce-Shaikh, B., Cua, D. J. and Stadecker, M. J., IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J. Immunol. 2008. 180: 24862495.
  • 22
    Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 15351541.
  • 23
    Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A. and Goverman, J. M., Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008. 14: 337342.
  • 24
    Mills, K. H., Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 2008. 38: 26362649.
  • 25
    Hu, X. and Ivashkiv, L. B., Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009. 31: 539550.
  • 26
    Damsker, J. M., Hansen, A. M. and Caspi, R. R., Th1 and Th17 cells: adversaries and collaborators. Ann. NY Acad. Sci. 2010. 1183: 211221.
  • 27
    Gao, J. L., Sen, A. I., Kitaura, M., Yoshie, O., Rothenberg, M. E., Murphy, P. M. and Luster, A. D., Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. 1996. 223: 679684.
  • 28
    Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. and Iwakura, Y., IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 2003. 100: 59865990.
  • 29
    Shainheit, M. G., Smith, P. M., Bazzone, L. E., Wang, A. C., Rutitzky, L. I. and Stadecker, M. J., Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology. J. Immunol. 2008. 181: 85598567.
  • 30
    Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y. H. et al., Regulation of inflammatory responses by IL-17F. J. Exp. Med. 2008. 205: 10631075.
  • 31
    Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen- presenting cells. Immunity 1999. 10: 137142.
  • 32
    Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M. et al., Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004. 20: 623635.
  • 33
    Rutitzky, L. I., Smith, P. M. and Stadecker, M. J., T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation. Eur. J. Immunol. 2009. 39: 24702481.
  • 34
    Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000. 100: 655669.
  • 35
    Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P. and Glimcher, L. H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002. 295: 338342.
  • 36
    Ylikoski, E., Lund, R., Kylaniemi, M., Filen, S., Kilpelainen, M., Savolainen, J. and Lahesmaa, R., IL-12 up-regulates T-bet independently of IFN-gamma in human CD4+T cells. Eur. J. Immunol. 2005. 35: 32973306.
  • 37
    Mohr, E., Cunningham, A. F., Toellner, K. M., Bobat, S., Coughlan, R. E., Bird, R. A., MacLennan, I. C. and Serre, K., IFN-gamma produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc. Natl. Acad. Sci. USA. 2010. 107: 1729217297.
  • 38
    Lazarevic, V., Chen, X., Shim, J. H., Hwang, E. S., Jang, E., Bolm, A. N., Oukka, M. et al., T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 2011. 12: 96104.
  • 39
    Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y., Hood, L. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 11331141.
  • 40
    Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 11231132.
  • 41
    Irmler, I. M., Gajda, M. and Brauer, R., Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 2007. 179: 62286236.
  • 42
    Kim, E. Y., Chi, H. H., Bouziane, M., Gaur, A. and Moudgil, K. D., Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma. Clin. Immunol. 2008. 127: 98106.
  • 43
    Kelchtermans, H., Schurgers, E., Geboes, L., Mitera, T., Van Damme, J., Van Snick, J., Uyttenhove, C. and Matthys, P., Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res. Ther. 2009. 11: R122.
  • 44
    Doodes, P. D., Cao, Y., Hamel, K. M., Wang, Y., Rodeghero, R. L., Mikecz, K., Glant, T. T. et al., IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J. Immunol. 2010. 184: 15521559.
  • 45
    Cihakova, D. and Rose, N. R., Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008. 99: 95114.
  • 46
    Valaperti, A., Marty, R. R., Kania, G., Germano, D., Mauermann, N., Dirnhofer, S., Leimenstoll, B. et al., CD11b+monocytes abrogate Th17 CD4+T cell-mediated experimental autoimmune myocarditis. J. Immunol. 2008. 180: 26862695.
  • 47
    Afanasyeva, M., Georgakopoulos, D., Belardi, D. F., Bedja, D., Fairweather, D., Wang, Y., Kaya, Z. et al., Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci. USA 2005. 102: 180185.
  • 48
    Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J. et al., IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 2006. 203: 24852494.
  • 49
    Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P. et al., Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008. 205: 799810.
  • 50
    Happel, K. I., Dubin, P. J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L. J., Odden, A. R. et al., Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 2005. 202: 761769.
  • 51
    Khader, S. A., Pearl, J. E., Sakamoto, K., Gilmartin, L., Bell, G. K., Jelley-Gibbs, D. M., Ghilardi, N. et al., IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 2005. 175: 788795.
  • 52
    Higgins, S. C., Jarnicki, A. G., Lavelle, E. C. and Mills, K. H., TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 2006. 177: 79807989.
  • 53
    Masters, S. L., Mielke, L. A., Cornish, A. L., Sutton, C. E., O'Donnell, J., Cengia, L. H., Roberts, A. W. et al., Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep. 2010. 11: 640646.
  • 54
    Flores-Villanueva, P. O., Zheng, X. X., Strom, T. B. and Stadecker, M. J., Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 1996. 156: 33153320.
  • 55
    Bazzone, L. E., Smith, P. M., Rutitzky, L. I., Shainheit, M. G., Urban, J. F., Setiawan, T., Blum, A. M. et al., Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. Infect. Immun. 2008. 76: 51645172.
  • 56
    Kolls, J. K. and Linden, A., Interleukin-17 family members and inflammation. Immunity 2004. 21: 467476.
  • 57
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 58
    Ouyang, W., Kolls, J. K. and Zheng, Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008. 28: 454467.
  • 59
    Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K. et al., Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002. 17: 375387.
  • 60
    Boros, D. and Warren, K., Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni soluble eggs. J. Exp. Med. 1970. 132: 488507.
  • 61
    Chen, Y., Langrish, C. L., McKenzie, B., Joyce-Shaikh, B., Stumhofer, J. S., McClanahan, T., Blumenschein, W. et al., Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 2006. 116: 13171326.
  • 62
    Rutitzky, L. I., Mirkin, G. A. and Stadecker, M. J., Apoptosis by neglect of CD4+Th cells in granulomas: a novel effector mechanism involved in the control of egg-induced immunopathology in murine schistosomiasis. J. Immunol. 2003. 171: 18591867.